NASDAQ / LIVE COMPANY INTELLIGENCE

Assembly Biosciences, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERASMB
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / ASMB COVERAGE

What’s moving Assembly Biosciences, Inc. now

Current reporting with the operating signal separated from the noise.

01
Assembly Biosciences, Inc. (ASMB) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Assembly Biosciences, Inc. (ASMB) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

The story matters when it changes Assembly Biosciences, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Assembly Biosciences, Inc. (ASMB) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Assembly Biosciences, Inc. (ASMB) Presents at Bank of America Global Healthcare Conference 2026 Transcript

The story matters when it changes Assembly Biosciences, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Assembly Biosciences, Inc. (ASMB) Announces Key Leadership and Plan Changes

Assembly Biosciences, Inc. (ASMB) Announces Key Leadership and Plan Changes

The story matters when it changes Assembly Biosciences, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Is Assembly Biosciences, Inc. (ASMB) Among Stocks With At Least $20 Million In Insider Spending Recently?

Is Assembly Biosciences, Inc. (ASMB) Among Stocks With At Least $20 Million In Insider Spending Recently?

Investors are testing whether Assembly Biosciences, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest ASMB filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-07 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-10 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-19 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-05 · Period 2026-06-04SEC ↗8-KMaterial company eventFiled 2026-05-26 · Period 2026-05-21SEC ↗8-KMaterial company eventFiled 2026-05-22 · Period 2026-05-22SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-22 · Period 2026-06-04SEC ↗4Official SEC filingFiled 2026-06-18 · Period 2026-06-17SEC ↗
EARNINGS / QUARTERLY TRACKER

Assembly Biosciences, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.